UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis

Digestive and liver disease, 2022-10, Vol.54 (10), p.1392-1402

2022

Volltextzugriff (PDF)

TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways

Biochemical and biophysical research communications, 2004-11, Vol.324 (1), p.440-445

2004

Volltextzugriff (PDF)

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway

The Journal of nutritional biochemistry, 2021-03, Vol.89, p.108573-108573, Article 108573

2021

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice

Biochimica et biophysica acta. Molecular basis of disease, 2023-10, Vol.1869 (7), p.166770-166770, Article 166770

2023

Volltextzugriff (PDF)

Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis

Biochimica et biophysica acta. Molecular cell research, 2024-02, Vol.1871 (2), p.119649-119649, Article 119649

2024

Volltextzugriff (PDF)

Su1049 Changes in Fatty Liver Over the Past 20 Years: Association With Lifestyle-Related Diseases

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1049-S-1050

2015

Volltextzugriff (PDF)

Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin

The Journal of nutritional biochemistry, 2023-12, Vol.122, p.109450-109450, Article 109450

2023

Volltextzugriff (PDF)

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study

Clinical gastroenterology and hepatology, 2024-01, Vol.22 (1), p.113-123.e9

2024

Volltextzugriff (PDF)

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study

Clinical gastroenterology and hepatology, 2024-01, Vol.22 (1), p.102-112.e9

2024

Volltextzugriff (PDF)

THU-291-Is non-alcoholic fatty liver disease a risk factor for chronic kidney disease?

Journal of hepatology, 2019-04, Vol.70 (1), p.e288-e288

2019

Volltextzugriff (PDF)

FRI-020-Identification of risk factors for histological progression with sequential liver biopsies in primary cholangitis patients

Journal of hepatology, 2019-04, Vol.70 (1), p.e392-e392

2019

Volltextzugriff (PDF)

THU-174-Efficacy of L-Carnitine on the ribavirin induced hemolytic anemia for patients with HCV infection

Journal of hepatology, 2019-04, Vol.70 (1), p.e238-e238

2019

Volltextzugriff (PDF)

FRI-332-Effect of combined farnesoid X receptor agonist and angiotensin 2 receptor blocker on established liver fibrosis in rats

Journal of hepatology, 2019-04, Vol.70 (1), p.e542-e542

2019

Volltextzugriff (PDF)

FRI-342-Combining probiotics and an angiotensin-2 type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis

Journal of hepatology, 2019-04, Vol.70 (1), p.e545-e546

2019

Volltextzugriff (PDF)

Protecting human security: proposals for the G7 Ise-Shima Summit in Japan

The Lancet (British edition), 2016-05, Vol.387 (10033), p.2155-2162

Japan Global Health Working Group

2016

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis

TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway

Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice

Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis

Su1049 Changes in Fatty Liver Over the Past 20 Years: Association With Lifestyle-Related Diseases

Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study

THU-291-Is non-alcoholic fatty liver disease a risk factor for chronic kidney disease?

FRI-020-Identification of risk factors for histological progression with sequential liver biopsies in primary cholangitis patients

THU-174-Efficacy of L-Carnitine on the ribavirin induced hemolytic anemia for patients with HCV infection

FRI-332-Effect of combined farnesoid X receptor agonist and angiotensin 2 receptor blocker on established liver fibrosis in rats

FRI-342-Combining probiotics and an angiotensin-2 type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non-alcoholic steatohepatitis

Protecting human security: proposals for the G7 Ise-Shima Summit in Japan

Aktive Filter

Suchergebnisse filtern